PAPA-DEINE #4 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Papa-deine #4, and when can generic versions of Papa-deine #4 launch?
Papa-deine #4 is a drug marketed by Vangard and is included in one NDA.
The generic ingredient in PAPA-DEINE #4 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Papa-deine #4
A generic version of PAPA-DEINE #4 was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.
Summary for PAPA-DEINE #4
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PAPA-DEINE #4 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PAPA-DEINE #4
US Patents and Regulatory Information for PAPA-DEINE #4
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vangard | PAPA-DEINE #4 | acetaminophen; codeine phosphate | TABLET;ORAL | 088715-001 | Mar 20, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |